Search Results

Learn how Dr. GPCR Ecosystem ensures your privacy with our comprehensive Privacy Policy. Privacy Policy Dr. GPCR, Corp (“Dr. Please read carefully our Legal Policies and Disclaimers to understand how Dr.

Details 3️⃣ Complete the Payment 4️⃣ Activate Memberships Select Terry’s Pharmacology Corner — Created by Dr Terry Kenakin , powered by Dr. GPCR . Stay connected on LinkedIn and YouTube .

This is a rare neurodevelopmental disorder caused by de novo mutations in the GRIN genes that encode The Ramsey Lab Amy Ramsey on the web University of Toronto Pubmed Google Scholar LinkedIn Twitter Dr. GPCR Previous Event Next Event Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec

Conference History The GPCR Retreat is an annual joint meeting with the Club des récepteurs à Sept Domaines The following year, the Great Lakes GPCR Retreat partnered with the annual symposium of the Club des

This week, we introduce the newly structured Dr. Dr. 2026 Sharpening GPCR Drug Discovery Decisions Read Full Issue February 6 - 12, 2026 A New Era for the Dr 1 2 3 4 5 6 7 8 9 ... 9 About GPCR Weekly News GPCR Weekly News was launched in 2020 as part of the Dr

novel therapeutics. " Yao Lu (Jackie) on the web Monash University Georgina Sweet Fellowship Authorea Dr GPCR Enjoying the Dr. GPCR Podcast? Leave a Review.

Discover special university group pricing for Dr. GPCR courses. Empower Your Team with Dr. Each person must have or create a Dr. Contact us at Hello@DGPCR.org Book Plan Your Next Move in GPCR Discovery Meet directly with Dr.

Saraf on the web FRAXA Research Foundation Google Scholar ResearchGate LinkedIn Dr. GPCR Enjoying the Dr. GPCR Podcast? Leave a Review.

Get in touch Connect LinkedIn Podcast Dr. GPCR Calendly ©2023-2025 All rights reserved by FindYooour, LLC & Dr.

Discover the rules and guidelines that govern your participation in the Dr. GPCR Ecosystem. Terms and Conditions Dr. GPCR, Corp (“Dr. GPCR”) provides its Service to you through our websites referred to as Dr. Dr. GPCR, Corp (“Dr. Dr. GPCR, Corp (“Dr. GPCR”) may change this ATS from time to time without prior notice.

Nicole (Nicki) Perry-Hauser on the web LinkedIn Research Gate Pubmed Dr. GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review.

<< Back to podcast list Strategic Partner(s) You never know where your GPCR takes you with Dr. Brian Hudson on the web University of Glasgow Enjoying the Dr. GPCR Podcast? Leave a Review.

Join Dr. GPCR Ecosystem and collaborate with us to make a positive impact.

Thank you for joining the Dr. GPCR Ecosystem!

Genemode on the web Website Jacob Lee on LinkedIn Jacob Lee on Dr. GPCR Ecosystem Jin Choe on LinkedIn Jin Choe on Dr. GPCR Ecosystem Enjoying the Dr. GPCR Podcast?

board games. " Gáspár Pándy-Szekeres on the web LinkedIn University of Copenhagen ResearchGate Twitter Dr GPCR Enjoying the Dr. GPCR Podcast? Leave a Review.

The Practical Assessment of Signaling Bias Dr. Terry Kenakin < Back Workshop Summary Join Dr. Dr. Dr. Dr. Terry Kenakin’s workshop offers a fresh perspective on drug discovery .

lipid rafts, bitter taste receptor pharmacology, and data integration in this expert interview with Dr to podcast list Strategic Partner(s) How Lipid Rafts Organize GPCR Signaling This episode features Dr Dr. Dr. Guest on the Web LinkedIn 7TMR-RAFT database Enjoying the Dr. GPCR Podcast? Leave a Review.

If you're a Dr. Ecosystem member 01 Register for the event 02 Accept the invitation to the private group If you're not a Dr

Access expert CRO advisory services through the Dr. GPCR Ecosystem. Get in touch Connect LinkedIn Podcast Dr. GPCR Calendly ©2023-2025 All rights reserved by FindYooour, LLC & Dr.

Dr. Dr. About Martin Marro Dr. Dr. Guest on The Web LinkedIn Enjoying the Dr. GPCR Podcast? Leave a Review.

Tunaboylu on the web Antiverse DSV Future of Drug Discovery Podcast Twist Bioscience LinkedIn Twitter Dr property prediction since 2017" Ben Holland on the web Antiverse The Antibody Society YT LinkedIn Twitter Dr GPCR Enjoying the Dr. GPCR Podcast? Leave a Review.

to podcast list Strategic Partner(s) When to Walk, When to Run: Lessons from the GPCR Trenches with Dr Host Dr. About Ben Clements Dr. Dr. Ben Clements on the web University of Michigan X Google Scholar LinkedIn Enjoying the Dr.

Dr. Heidi Hamm on the web The Hamm Lab Vanderbilt School of Medicine Pubmed Google Scholar LinkedIn Twitter Dr GPCR Previous Event Next Event Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec

In this episode, Dr. Dr. development models Anyone curious about where AI meets molecular pharmacology About Ajay Yekkirala Dr That “failure” became a launchpad: Ajay later joined the lab of Dr. Enjoying the Dr. GPCR Podcast? Leave a Review.

stay ahead of the science Designed for biotech, pharma & academic researchers Live monthly AMA with Dr Each person must have or create a Dr. Contact us at Hello@DGPCR.org Terry’s Pharmacology Corner — Created by Dr. Terry Kenakin , powered by Dr. GPCR . Stay connected on LinkedIn and YouTube .

for imaging endogenous incretin receptors across biological systems 📅 March 3, 2026 at 3:00:00 PM 🤝 Dr Speaker Introductions Dr. Dr. of Diabetic Medicine Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford Dr GPCR Dr.

Your One-Stop-Shop for GPCR Drug Discovery and Development Researchers developing GPCR-targeted therapeutics need a reliable, comprehensive partner that spans discovery, optimization, and regulatory submission. Eurofins DiscoverX leads GPCR research innovation with 25+ years of expertise and provides you with product solutions including cell-based assays for basic research through therapeutic discovery and development. The assays are validated and accepted by industry and the scientific community, with thousands of peer-reviewed publications and billions of data points screened. These industry-standard assays, designed for regulatory submissions, are backed by partnerships with leading pharma and biotech companies worldwide. GPCR Product Solutions Determine rank-order hits, evaluate ligand bias or allostery, study multiple targets and signaling pathways, investigate target species variations, deorphanize receptors, and more Perform target identification and validation, high-throughput screening (HTS), lead optimization, safety assessment, and regulatory potency testing for commercial release Access a complete toolkit for GPCR solutions: cell line assay kits, cell lines, ready-to-use assays, detection kits, custom products, and more Comprehensive Coverage >1500 Human GPCRs products, including: 90% Target coverage Orphan receptors Ortholog variants Multiple cell line backgrounds Multiple Mechanisms of Actions (MOA) cAMP accumulation β-Arrestin recruitment Receptor internalization Ligand binding Calcium flux Pharmaco Chaperone discovery Numerous Product Types Cell line assay kits Cell lines Qualified bioassays eXpress assay kits Membrane preps Detection kits Custom products Services Flexible Formats for Every Research Need Eurofins DiscoverX understands that different research stages require different tools. This comprehensive portfolio offers multiple product formats to match your exact needs, whether you're conducting exploratory screens or regulatory-compliant potency testing. Assay Principle of Eurofins DiscoverX Cell-based Assays Whether you are developing small-molecule or biologic therapeutic drugs, Eurofins DiscoverX provides you with a variety of drug discovery and development products with multiple assay types and applications to meet your specific GPCR research needs. Access Product Solutions and Key Resources GPCR Functional Cell-Based Assays - Assessing Biased Signaling of Agonist Access White Paper Discover Your GPCR Solution - Find The Assay for Your Target of Interest Find Your Solutions The Human GPCRome - Obtain Your FREE Wall Poster for Your Laboratory Obtain Wall Poster Access GPCR Cell Line Assays, Ready-to-Use Kits, Mem Preps, & More Shop Products Supporting GPCR-focused Obesity and Diabetes Research Eurofins DiscoverX supports the ongoing obesity/diabetes revolution with the most comprehensive, validated portfolio for obesity and diabetes GPCR targets, including GLP-1, GIP, GCG, MC4, PYY, AMY receptors, and more. Browse products related to your obesity/diabetes target of interest: CALCRL and RAMP (AMs) GIPR GLP-1R GLP-2R GCGR GPR75 MC4R NPY2R (PYY) SSTR5 Activins CALCR and RAMPs (AMYs) Apelin (APJ/AGTRL1) View representative data: GLP-1R multi-MOA profiling Eurofins DiscoverX's GLP-1 receptor (GLP-1R) assay portfolio illustrates a comprehensive approach to obesity research, with complete MOA coverage for a single target: GLP-1. These assays enable complete pharmacological profiling across cAMP, β-arrestin, and internalization. GLP-1R representative assay results (dose-response curves) for exendin-4, tirzepatide, and retatrutide. A. cAMP dose–response; B. β-arrestin recruitment showing ligand bias; and C. Internalization profiles distinguishing highly versus weakly internalizing agonists. Together, these datasets exemplify the depth of pharmacological insight enabled by Eurofins DiscoverX platforms. This multi-dimensional characterization extends across our full obesity and diabetes product portfolio, including GIPR, GCGR, AMY receptors, MC4R, and beyond. Access GPCR Obesity and Diabetes Solutions and Key Resources Discover GPCR Obesity and Diabetes Product Solutions Find Your Solution Review GIP Product Solutions to Support Obesity/Diabetes View GIP Solutions Explore GLP-1 Product Solutions to Support Obesity/Diabetes See GLP-1 Solutions Accelerating Obesity Therapeutics Development Download App Note Beyond Eurofins DiscoverX Products: The Full Power of Eurofins Discovery Eurofins DiscoverX cell lines, assays, kits, and custom product solutions represent the foundation of tools for GPCR research and drug discovery and development. When these product solutions are combined with Calixar GPCR membrane proteins and Eurofins Discovery GPCR services, the benefits from integration provide the most comprehensive GPCR research and drug discovery platform spanning the entire discovery and development continuum. Eurofins Discovery GPCR services provides the industry's most extensive collection of validated GPCR assays with hundreds of binding and functional assays, available individually or in panels. These assays use the same platform as the Eurofins DiscoverX assays and beyond. Calixar GPCR membrane proteins , as a service, provides a wide array of GPCRs from various species, purified to the highest standards to ensure purity, integrity, and biological activity. These GPCRs are excellent for use in functional, structural, or identification assays. Let us Help You Get Started! Contact us Visit GPCR Product Solutions

Join Dr. GPCR Ecosystem and promote a positive online community. Content and Conduct Policy Dr. GPCR, Corp, LLC (“Dr. GPCR”) provides its Service to you through our websites referred to as Dr. Please read carefully our Legal Policies and Disclaimers to understand how Dr.

1:00 PM Complimentary Lunch Read More 2:00 PM Posters Caroline Formstone · Jianxiang Xue · Virginea de roles of AGPCRs in the nervous system Beatriz Blanco Redondo · Willem Berend Post Read More 11:10 AM Dr the periphery Tobias Langenhan · Anastasia Georgiadi · Douglas Tilley · Hee-Yong Kim · Alain Garcia De GPR124 Mediates Adhesion Of Leukemic Stem Cells To Their Niche And Leads To Myeloid Skewing Virginea de Cheng-Chih Hsiao ADGRG1/GPR56 regulates survival of terminally differentiated CD8+ T cells Alain Garcia De